The Beauty Health Co (The Beauty Health Co) EBIT : $-66.0 Mil (TTM As of Mar. 2024)

View and export this data going back to 2021. Start your Free Trial

What is The Beauty Health Co EBIT?

The Beauty Health Co's earnings before interest and taxes (EBIT) for the three months ended in Mar. 2024 was $1.7 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Mar. 2024 was $-66.0 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. The Beauty Health Co's annualized ROC % for the quarter that ended in Mar. 2024 was -10.73%. The Beauty Health Co's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2024 was 6.79%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. The Beauty Health Co's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2024 was -11.43%.

The Beauty Health Co EBIT Historical Data

The historical data trend for The Beauty Health Co's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

The Beauty Health Co EBIT Chart

The Beauty Health Co Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

EBIT

Get a 7-Day Free Trial

14.16

-17.21

-368.86

58.73

-88.24

The Beauty Health Co Quarterly Data
	Dec18	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
EBIT	Get a 7-Day Free Trial														-20.50	4.60	-66.89	-5.44	1.69

Competitive Comparison of The Beauty Health Co's EBIT

For the Household & Personal Products subindustry, The Beauty Health Co's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

The Beauty Health Co's EV-to-EBIT Distribution in the Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, The Beauty Health Co's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where The Beauty Health Co's EV-to-EBIT falls into.

The Beauty Health Co EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-66.0 Mil.

The Beauty Health Co (NAS:SKIN) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

The Beauty Health Co's annualized ROC % for the quarter that ended in Mar. 2024 is calculated as:

	ROC % (Q: Mar. 2024 )
=	NOPAT	/	Average Invested Capital
=	Operating Income * ( 1 - Tax Rate % )	/	( (Invested Capital (Q: Dec. 2023 )	+	Invested Capital (Q: Mar. 2024 ))	/ count )
=	-67.964 * ( 1 - 49.25% )	/	( (320.692	+	322.089)	/ 2 )
=	-34.49173	/	321.3905
=	-10.73 %

where

	Invested Capital		(Q: Dec. 2023 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	929.113	-	85.396	-	( 523.025	-	max(0, 115.008	-	698.252	+	523.025	))
=	320.692

	Invested Capital		(Q: Mar. 2024 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	844.741	-	78.018	-	( 444.634	-	max(0, 93.568	-	614.824	+	444.634	))
=	322.089

Note: The Operating Income data used here is four times the quarterly (Mar. 2024) data.

2. Joel Greenblatt's definition of Return on Capital:

The Beauty Health Co's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2024 is calculated as:

	ROC (Joel Greenblatt) %		(Q: Mar. 2024 )
=	EBIT	/	Average of (Net fixed Assets	+	Net Working Capital)
=	EBIT	/	Average of (Property, Plant and Equipment	+	Net Working Capital)
			Q: Dec. 2023		Q: Mar. 2024
=	EBIT	/	( ( (Property, Plant and Equipment + Net Working Capital)	+	(Property, Plant and Equipment + Net Working Capital) )	/	count )
=	6.764	/	( ( (26.346 + max(64.485, 0))	+	(28.431 + max(80.066, 0)) )	/	2 )
=	6.764	/	( ( 90.831	+	108.497 )	/	2 )
=	6.764	/	99.664
=	6.79 %

where Working Capital is:

	Working Capital		(Q: Dec. 2023 )
=	(Accounts Receivable	+	Total Inventories	+	Other Current Assets)	-	(Accounts Payable & Accrued Expense	+	Defer. Rev.	+	Other Current Liabilities)
=	(54.697	+	91.321	+	28.877)	-	(85.396	+	0	+	25.014)
=	64.485

	Working Capital		(Q: Mar. 2024 )
=	(Accounts Receivable	+	Total Inventories	+	Other Current Assets)	-	(Accounts Payable & Accrued Expense	+	Defer. Rev.	+	Other Current Liabilities)
=	(47.666	+	95.721	+	25.599)	-	(78.018	+	0	+	10.902)
=	80.066

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Mar. 2024) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

The Beauty Health Co's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %	=	EBIT (TTM)	/	Enterprise Value (Q: Mar. 2024 )
	=	-66.045	/	577.940
	=	-11.43 %

The Beauty Health Co EBIT Related Terms

Thank you for viewing the detailed overview of The Beauty Health Co's EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

The Beauty Health Co (The Beauty Health Co) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » The Beauty Health Co (NAS:SKIN) » Definitions » EBIT

Comparable Companies

Traded in Other Exchanges

V7A0:Germany

Address

2165 Spring Street, Long Beach, CA, USA, 90806

Website

https://www.beautyhealth.com

The Beauty Health Co is a category-creating beauty health company focused on bringing innovative products to market. The company's flagship brand HydraFacial is a non-invasive, and approachable beauty health platform and ecosystem with a powerful community of estheticians, consumers and partners, bridging medical and consumer retail to democratize and personalize skin care solutions for the masses. Geographically, it derives a majority of revenue from the Americas.

Executives

Michael D Capellas	director	C/O MCI, 22001 LOUDOUN COUNTY PARKWAY, AXBURN VA 20147
Brian Christopher Miller	10 percent owner	1819 WEST AVENUE, BAY 2, MIAMI BEACH FL 33139
Andrew Roy Stanleick	director, officer: Chief Executive Officer	C/O THE BEAUTY HEALTH COMPANY, 2165 SPRING STREET, LONG BEACH CA 90806
Michael P. Monahan	officer: Chief Financial Officer	9 PENARTH ROAD, BALA CYNWYD PA 19004
Brent L Saunders	director, officer: Executive Chairman	2000 GALLOPING HILL ROAD, C/O SCHERING PLOUGH CORP, KENILWORTH NJ 07033
Julius Few	director	1819 WEST BAY 2, MIAMI FL 33139
Doug K. Schillinger	director	1819 WEST AVENUE, BAY 2, MIAMI BEACH FL 33139
Desiree Gruber	director	C/O DPCM CAPITAL, INC., 382 NE 191 STREET, #24148, MIAMI FL 33179
Marla Malcolm Beck	director	C/O THE CHILDREN'S PLACE, INC., 500 PLAZA DRIVE, SECAUCUS NJ 07094
Bradley Hauser	officer: Chief Operating Officer	C/O ZELTIQ AESTHETICS, INC., 4698 WILLOW ROAD, SUITE 100, PLEASANTON CA 94588
Stephan Becker	officer: President, EMEA	2165 SPRING STREET, LONG BEACH CA 90806
Indra Pamamull	officer: President, APAC	C/O THE BEAUTY HEALTH COMPANY, 2165 SPRING STREET, LONG BEACH CA 90806
Liyuan Woo	officer: Chief Financial Officer	400 VALLEY DRIVE, BRISBANE CA 94005
Watson Daniel Copell	officer: See Remarks	1819 WEST AVENUE, BAY 2, MIAMI BEACH FL 33139
Lcp Edge Holdco Llc	10 percent owner	150 NORTH RIVERSIDE PLAZA, SUITE 5100, CHICAGO IL 60606